Biofourmis, Oura: Investing in Always-On Cardiac AI Surveillance
The landscape of cardiac monitoring is undergoing a profound transformation, shifting from a reactive, episodic paradigm to one…
The landscape of cardiac monitoring is undergoing a profound transformation, shifting from a reactive, episodic paradigm to one…
The valuation of Viz.ai at $1.2 billion USD represents a critical inflection point in the health AI landscape,…